Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism-Reference-Cited by-同舟云学术

Loss of G0/G1 switch gene 2 (G0S2) promotes disease progression and drug resistance in chronic myeloid leukaemia (CML) by disrupting glycerophospholipid metabolism

Published:2022-12 Issue:12 Volume:12 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical & Translational Med

Author:

Gonzalez Mayra A.¹^ORCID,Olivas Idaly M.¹²^ORCID,Bencomo‐Alvarez Alfonso E.¹^ORCID,Rubio Andres J.¹³,Barreto‐Vargas Christian⁴^ORCID,Lopez Jose L.³,Dang Sara K.²³,Solecki Jonathan P.²,McCall Emily³,Astudillo Gonzalo³,Velazquez Vanessa V.³,Schenkel Katherine³,Reffell Kelaiah²,Perkins Mariah³,Nguyen Nhu³,Apaflo Jehu N.⁵,Alvidrez Efren⁶,Young James E.²,Lara Joshua J.²³,Yan Dongqing⁷,Senina Anna⁷,Ahmann Jonathan⁷,Varley Katherine E.⁷^ORCID,Mason Clinton C.⁷,Eide Christopher A.⁸,Druker Brian J.⁸^ORCID,Nurunnabi Md⁶^ORCID,Padilla Osvaldo⁹,Bajpeyi Sudip⁵^ORCID,Eiring Anna M.¹²³^ORCID

Affiliation:

1. Department of Molecular and Translational Medicine Center of Emphasis in Cancer Texas Tech University Health Sciences Center El Paso El Paso Texas USA

2. L. Frederick Francis Graduate School of Biomedical Sciences Texas Tech University Health Sciences Center El Paso El Paso Texas USA

3. Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso El Paso Texas USA

4. Immunology Division University of Guadalajara Guadalajara Jalisco Mexico

5. Metabolic, Nutrition and Exercise Research (MiNER) Laboratory, Department of Kinesiology University of Texas at El Paso El Paso Texas USA

6. Department of Pharmaceutical Sciences School of Pharmacy University of Texas at El Paso El Paso Texas USA

7. Huntsman Cancer Institute The University of Utah Salt Lake City Utah USA

8. Knight Cancer Institute Division of Hematology/Medical Oncology Oregon Health & Science University Portland Oregon USA

9. Department of Pathology Texas Tech University Health Sciences Center El Paso El Paso Texas USA

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.1146

Reference86 articles.

1. A minute chromosome in human chronic granulocytic leukemia;Nowell PC;Science,1960

2. Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia

3. The biology of CML blast crisis

4. Pushing the limits of targeted therapy in chronic myeloid leukaemia

5. Primitive, quiescent, Philadelphia-positive stem cells from patients with chronic myeloid leukemia are insensitive to STI571 in vitro

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 Detection;Cells;2024-04-02

2. Bone marrow adipocyte: Origin, biology and relationship with hematological malignancy;International Journal of Laboratory Hematology;2023-11-05

3. The acquisition order of leukemic drug resistance mutations is directed by the selective fitness associated with each resistance mechanism;Scientific Reports;2023-08-11

4. Variation in Lipid Species Profiles among Leukemic Cells Significantly Impacts Their Sensitivity to the Drug Targeting of Lipid Metabolism and the Prognosis of AML Patients;International Journal of Molecular Sciences;2023-03-22